cefazolin (Ancef, Kefzol)
Jump to navigation
Jump to search
Introduction
Tradenames: Ancef, Kefzol. 1st generation cephalosporin.
Indications
- treatment of serious infections caused by susceptible gram positive & gram negative organisms
- surgical prophylaxis against Staphylococci
- administered 60 minutes prior to procedure
- repeated during procedures lasting more than 4 hours
- prophylaxis for bacterial endocarditis[6]
Contraindications
- cefazolin allergy is rare in persons reporting penicillin allergy[7]
Dosage
Children: 25-50 mg/kg/day divided every 6-8 hours.
Severe infections: 100 mg/kg/day.
Pharmacokinetics
- time to peak serum concentration: 5 min (IV), 0.5-2 h (IM)
- elimination 1/2 life 1.5-2.5 hours (40-70 hours ESRD)
- 80-100% eliminated unchanged in the urine
- dosage adjustment with renal failure (see below)
- protein binding 74-86%
- distributed to most tissues
- does not achieve therapeutic levels in CNS
- removed by hemodialysis Dosage adjustment with renal failure:
Creatinine clearance | dose |
---|---|
> 50 mL/min | 1 g IV/IM every 8 hours |
10-49 mL/min | 1 g 1V/IM every 12 hours |
< 9 mL/min | 0.5 g IV/IM every 12 hours |
post dialysis | 0.5-1 g IV/IM |
elimination via kidney
1/2life = 1.8 hours
protein binding = 75-86 %
elimination by hemodialysis = +
elimination by peritoneal dialysis = -
Antimicrobial activity
- Neisseria gonorrhoeae
- Moraxella catarrhalis
- Haemophilus influenzae
- Escherichia coli
- Klebsiella species
- Proteus mirabilis
Notable lack of activity against enterococcus, MRSA & anaerobes.
Adverse effects
- not common (1-10%)
- uncommon (< 1%)
- CNS irritation, seizures, abdominal cramps, fever, rash, eosinophilia, decreased prothrombin, urticaria, leukopenia, pseudomembranous colitis, thrombocytopenia, transient increase in serum alkaline phosphatase & transaminases, cholestatic jaundice, pain at site of injection, superinfection
- other
- hypersensitivity reactions
- lack of cross-reactivity between cefazolin & penicillin[8]
- cefazolin has no cross reactivity with any cephalosporin available in the U.S.[8]
- blood dyscrasias (rare)
- headache
- direct Coomb's test may be positive
- hypersensitivity reactions
Drug interactions
- probenecid increases the 1/2 life of cefazolin
- drug interaction(s) anticonvulsants with anti-bacterial agents
- drug interaction(s) of antibiotics with warfarin
Laboratory
- specimen:
- serum
- keep specimen on ice-water
- centrifuge at 4 degrees C
- remove cells as soon as possible
- freeze at -70 degrees C until assayed
- methods: HPLC, MB
Mechanism of action
- inhibition of bacterial cell wall synthesis.
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 161
- ↑ Sanford Guide to antimicrobial therapy 1997, 2001
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
- ↑ 6.0 6.1 Deprecated Reference
- ↑ 7.0 7.1 Sousa-Pinto B et al. Assessment of the frequency of dual allergy to penicillins and cefazolin: A systematic review and meta-analysis. JAMA Surg 2021 Mar 17; e210021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33729459 https://jamanetwork.com/journals/jamasurgery/article-abstract/2777647
- ↑ 8.0 8.1 8.2 Goh GS, Shohat N, Austin MS et al. A simple algorithmic approach allows the safe use of cephalosporin in "penicillin-allergic" patients without the need for allergy testing. J Bone Joint Surg Am 2021 Dec 15; 103:2261. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34644269 https://journals.lww.com/jbjsjournal/Abstract/2021/12150/A_Simple_Algorithmic_Approach_Allows_the_Safe_Use.2.aspx
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=33255
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=33730
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=656510
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2617
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=441387
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=441196